<?xml version="1.0" encoding="UTF-8"?>
<record
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xsi:schemaLocation="http://www.loc.gov/MARC21/slim http://www.loc.gov/standards/marcxml/schema/MARC21slim.xsd"
    xmlns="http://www.loc.gov/MARC21/slim">

  <leader>09108nam a2200421 a 4500</leader>
  <controlfield tag="005">20260513213927.0</controlfield>
  <controlfield tag="006">m        d        </controlfield>
  <controlfield tag="007">cr cnu---uuuuu</controlfield>
  <controlfield tag="008">171114s2017            s     000 0 eng d</controlfield>
  <datafield tag="020" ind1=" " ind2=" ">
    <subfield code="a">9783319488486</subfield>
    <subfield code="q">(eBook)</subfield>
  </datafield>
  <datafield tag="020" ind1=" " ind2=" ">
    <subfield code="a">9783319488462</subfield>
    <subfield code="q">(Hardback)</subfield>
  </datafield>
  <datafield tag="040" ind1=" " ind2=" ">
    <subfield code="a">CO-CtgCURN</subfield>
    <subfield code="b">spa</subfield>
    <subfield code="c">coctgcurn</subfield>
  </datafield>
  <datafield tag="082" ind1="0" ind2="4">
    <subfield code="a">616.99449</subfield>
    <subfield code="2">23</subfield>
  </datafield>
  <datafield tag="245" ind1="0" ind2="0">
    <subfield code="a">Breast cancer</subfield>
    <subfield code="h">[electronic resource] :</subfield>
    <subfield code="b">innovations in research and management /</subfield>
    <subfield code="c">Umberto Veronesi, Aron Goldhirsch, editors-in-chief ; Paolo Veronesi, Oreste Davide Gentilini, Maria Cristina Leonardi, editors.</subfield>
  </datafield>
  <datafield tag="260" ind1=" " ind2="4">
    <subfield code="a">Cham, Switzerland : : :</subfield>
    <subfield code="b">Springer,,,</subfield>
    <subfield code="c">2017.</subfield>
  </datafield>
  <datafield tag="260" ind1=" " ind2="1">
    <subfield code="c">2017.</subfield>
  </datafield>
  <datafield tag="300" ind1=" " ind2=" ">
    <subfield code="a">1 recurso en l&#xED;nea (xiv, 928 p&#xE1;ginas) :</subfield>
    <subfield code="b">ilustraciones (some color)</subfield>
  </datafield>
  <datafield tag="336" ind1=" " ind2=" ">
    <subfield code="a">texto</subfield>
    <subfield code="b">txt</subfield>
    <subfield code="2">rdacontent</subfield>
  </datafield>
  <datafield tag="337" ind1=" " ind2=" ">
    <subfield code="a">computador</subfield>
    <subfield code="b">c</subfield>
    <subfield code="2">rdamedia</subfield>
  </datafield>
  <datafield tag="338" ind1=" " ind2=" ">
    <subfield code="a">recurso en l&#xED;nea</subfield>
    <subfield code="b">cr</subfield>
    <subfield code="2">rdacarrier</subfield>
  </datafield>
  <datafield tag="504" ind1=" " ind2=" ">
    <subfield code="a">Incluye referencias bibliogr&#xE1;ficas e &#xED;ndice.</subfield>
  </datafield>
  <datafield tag="505" ind1="0" ind2=" ">
    <subfield code="a">Scellaneous Approaches -- Lifestyle and breast cancer -- Psychological support -- HIFU and radiofrequency as alternatives to surgery -- Hyperthermia with RT and with systemic therapies -- Electro-chemotherapy -- Circulating miRNA in early diagnosis -- Relevance&#xA0; of stem cells -- Part XII Biostatistics and Bioinformatics -- Subgroup analyses and information from clinical trials on&#xA0; breast cancer -- The methodology of meta analyses and its potential contribution to patient care -- Modern biostatistics&#xA0; for accelerated&#xA0; data acquisition for new drugs -- Bioinformatics for clinical use in breast cancer -- Efficacy endpoints in breast cancer studies and definitive&#xA0; implant replacement -- Breast reconstruction with pedicled flaps -- Breast reconstruction with free flaps -- Contralateral breast management -- Fat grafting in breast reconstruction -- Breast reconstruction with biological and nonbiological&#xA0; meshes -- How to manage complications in breast reconstruction -- Part VII Medical Oncology -- Adjuvant systemic therapies by subtypes: guidelines -- Primary systemic therapies: guidelines -- Treatment of advanced disease: guidelines -- Endocrine therapies in the adjuvant and advanced disease settings -- Chemotherapy regimens in the adjuvant and advanced disease settings -- Anti-HER2 therapies in the adjuvant and advanced disease settings -- Systemic therapy with bisphosphonates and anti-RANK-L agents -- Systemic treatment for specific medical situations -- Part VIII Radiotherapy -- Conceptual basis and principles of radiation oncology -- Whole breast radiation following breast-conserving surgery in invasive cancer -- Whole breast radiation following breast-conserving surgery in noninvasive cancer -- Post-mastectomy radiotherapy -- Integration of radiotherapy with systemic therapies -- Partial breast irradiation -- Intraoperative radiotherapy ELIOT -- Radiotherapy for metastatic lesions -- Part IX Special Conditions Requiring Multidisciplinary Approaches -- Emergencies in breast cancer -- Breast cancer during pregnancy -- Fertility issues in patients with newly diagnosed breast cancer -- Sexual functions and breast cancer -- Male breast cancer -- Inflammatory&#xA0; breast cancer -- Treatment of CNS involvement -- Treatment of skeletal disease -- Follow-up of patients with breast cancer -- Part X Investigating New Drugs and Immunological Agents in Breast Cancer -- Targeting immune-checkpoint -- Targeting PIK3CA/AKT/mTOR -- Targeting genome instability and DNA repair -- Targeting CDK4/6 pathway -- Targeting FGFR pathway -- Integrating next generation sequencing data in trial design -- Part XI Investigational and Mi.</subfield>
  </datafield>
  <datafield tag="520" ind1=" " ind2=" ">
    <subfield code="a">Este libro proporciona al lector informaci&#xF3;n actualizada sobre avances importantes en la comprensi&#xF3;n del c&#xE1;ncer de mama y enfoques innovadores para su manejo. Las perspectivas actuales y emergentes sobre gen&#xE9;tica, biolog&#xED;a y prevenci&#xF3;n se analizan primero en profundidad, y las secciones individuales se dedican a patolog&#xED;a, imagenolog&#xED;a, cirug&#xED;a oncol&#xF3;gica, cirug&#xED;a pl&#xE1;stica y reconstructiva, oncolog&#xED;a m&#xE9;dica y radioterapia. En cada caso, la atenci&#xF3;n se centra en el progreso m&#xE1;s reciente y / o las terapias y t&#xE9;cnicas de vanguardia. Otros temas para recibir una consideraci&#xF3;n detallada incluyen condiciones particulares que requieren enfoques multidisciplinarios, la investigaci&#xF3;n de nuevos f&#xE1;rmacos y agentes inmunol&#xF3;gicos, aspectos de estilo de vida y psicol&#xF3;gicos, y bioestad&#xED;stica e inform&#xE1;tica. El libro ser una excelente referencia para profesionales, pasantes y residentes en oncolog&#xED;a m&#xE9;dica, cirug&#xED;a oncol&#xF3;gica, radioterapia, patolog&#xED;a y gen&#xE9;tica humana, investigadores y estudiantes de medicina avanzados.</subfield>
  </datafield>
  <datafield tag="650" ind1=" " ind2="0">
    <subfield code="a">Pecho</subfield>
    <subfield code="x">Cancer.</subfield>
  </datafield>
  <datafield tag="650" ind1=" " ind2="0">
    <subfield code="a">Pecho</subfield>
    <subfield code="x">Cancer</subfield>
    <subfield code="x">Diagn&#xF3;stico.</subfield>
  </datafield>
  <datafield tag="650" ind1=" " ind2="0">
    <subfield code="a">Pecho</subfield>
    <subfield code="x">Cancer</subfield>
    <subfield code="x">Tratamiento.</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
    <subfield code="a">Veronesi, Umberto,</subfield>
    <subfield code="e">editor.</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
    <subfield code="a">Goldhirsch, A.</subfield>
    <subfield code="q">(Aron),</subfield>
    <subfield code="e">editor.</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
    <subfield code="a">Veronesi, Paolo,</subfield>
    <subfield code="e">editor.</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
    <subfield code="a">Gentilini, Oreste Davide,</subfield>
    <subfield code="e">editor.</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
    <subfield code="a">Leonardi, Maria Cristina,</subfield>
    <subfield code="e">editor.</subfield>
  </datafield>
  <datafield tag="852" ind1=" " ind2=" ">
    <subfield code="a">MHE</subfield>
    <subfield code="b">MHE</subfield>
    <subfield code="c">CF</subfield>
    <subfield code="h">616.99449</subfield>
    <subfield code="i">B828</subfield>
  </datafield>
  <datafield tag="856" ind1="7" ind2=" ">
    <subfield code="u">https://unicurn.sharepoint.com/:b:/s/biblioteca/EaZnuNQTNcpAm88PcsbQmzgBFAyFlr3HVtkXk_R36l0ixg?e=yY91jy</subfield>
    <subfield code="z">&lt;img src="/screens/gifs/go4.gif" alt="Go button" border="0" width="21" height="21" hspace="7" align=middle"&gt; Vea este libro electr&#xF3;nico</subfield>
  </datafield>
  <datafield tag="917" ind1="7" ind2="7">
    <subfield code="a">Scellaneous Approaches -- Lifestyle and breast cancer -- Psychological support -- HIFU and radiofrequency as alternatives to surgery -- Hyperthermia with RT and with systemic therapies -- Electro-chemotherapy -- Circulating miRNA in early diagnosis -- Relevance of stem cells -- Part XII Biostatistics and Bioinformatics -- Subgroup analyses and information from clinical trials on breast cancer -- The methodology of meta analyses and its potential contribution to patient care -- Modern biostatistics for accelerated data acquisition for new drugs -- Bioinformatics for clinical use in breast cancer -- Efficacy endpoints in breast cancer studies and definitive implant replacement -- Breast reconstruction with pedicled flaps -- Breast reconstruction with free flaps -- Contralateral breast management -- Fat grafting in breast reconstruction -- Breast reconstruction with biological and nonbiological meshes -- How to manage complications in breast reconstruction -- Part VII Medical Oncology -- Adjuvant systemic therapies by subtypes: guidelines -- Primary systemic therapies: guidelines -- Treatment of advanced disease: guidelines -- Endocrine therapies in the adjuvant and advanced disease settings -- Chemotherapy regimens in the adjuvant and advanced disease settings -- Anti-HER2 therapies in the adjuvant and advanced disease settings -- Systemic therapy with bisphosphonates and anti-RANK-L agents -- Systemic treatment for specific medical situations -- Part VIII Radiotherapy -- Conceptual basis and principles of radiation oncology -- Whole breast radiation following breast-conserving surgery in invasive cancer -- Whole breast radiation following breast-conserving surgery in noninvasive cancer -- Post-mastectomy radiotherapy -- Integration of radiotherapy with systemic therapies -- Partial breast irradiation -- Intraoperative radiotherapy ELIOT -- Radiotherapy for metastatic lesions -- Part IX Special Conditions Requiring Multidisciplinary Approaches -- Emergencies in breast cancer -- Breast cancer during pregnancy -- Fertility issues in patients with newly diagnosed breast cancer -- Sexual functions and breast cancer -- Male breast cancer -- Inflammatory breast cancer -- Treatment of CNS involvement -- Treatment of skeletal disease -- Follow-up of patients with breast cancer -- Part X Investigating New Drugs and Immunological Agents in Breast Cancer -- Targeting immune-checkpoint -- Targeting PIK3CA/AKT/mTOR -- Targeting genome instability and DNA repair -- Targeting CDK4/6 pathway -- Targeting FGFR pathway -- Integrating next generation sequencing data in trial design -- Part XI Investigational and Mi</subfield>
  </datafield>
  <datafield tag="917" ind1="9" ind2="9">
    <subfield code="a">This book provides the reader with up-to-date information on important advances in the understanding of breast cancer and innovative approaches to its management. Current and emerging perspectives on genetics, biology, and prevention are first discussed in depth, and individual sections are then devoted to pathology, imaging, oncological surgery, plastic and reconstructive surgery, medical oncology, and radiotherapy. In each case the focus is on the most recent progress and/or state of the art therapies and techniques. Further topics to receive detailed consideration include particular conditions requiring multidisciplinary approaches, the investigation of new drugs and immunological agents, lifestyle and psychological aspects, and biostatistics and informatics. The book will be an excellent reference for practitioners, interns and residents in medical oncology, oncologic surgery, radiotherapy, pathology, and human genetics, researchers, and advanced medical students</subfield>
  </datafield>
  <datafield tag="917" ind1="6" ind2="6">
    <subfield code="a">Includes bibliographical references</subfield>
  </datafield>
  <datafield tag="942" ind1=" " ind2=" ">
    <subfield code="c">CF</subfield>
    <subfield code="h">616.99449</subfield>
    <subfield code="i">B828</subfield>
    <subfield code="2">ddc</subfield>
  </datafield>
  <datafield tag="999" ind1=" " ind2=" ">
    <subfield code="c">7918</subfield>
    <subfield code="d">7918</subfield>
  </datafield>
  <datafield tag="952" ind1=" " ind2=" ">
    <subfield code="0">0</subfield>
    <subfield code="1">0</subfield>
    <subfield code="2">ddc</subfield>
    <subfield code="4">0</subfield>
    <subfield code="6">616_994490000000000_B828</subfield>
    <subfield code="7">0</subfield>
    <subfield code="8">CF</subfield>
    <subfield code="a">MHE</subfield>
    <subfield code="b">MHE</subfield>
    <subfield code="c">CF</subfield>
    <subfield code="d">2025-03-29</subfield>
    <subfield code="l">0</subfield>
    <subfield code="o">616.99449 B828</subfield>
    <subfield code="r">2025-03-29 17:09:40</subfield>
    <subfield code="y">CF</subfield>
    <subfield code="w">2025-03-29</subfield>
  </datafield>
</record>
